Sandy Spring Bank’s iShares Biotechnology ETF IBB Stock Holding History

Sandy Spring Bank’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$2.3M	Sell	17,984 -44	-0.2%	-$5.97K	0.1%	163
2024 Q4	$2.38M	Sell	18,028 -475	-3%	-$66.8K	0.1%	161
2024 Q3	$2.69M	Sell	18,503 -984	-5%	-$142K	0.11%	150
2024 Q2	$2.67M	Sell	19,487 -2,477	-11%	-$331K	0.12%	147
2024 Q1	$3.01M	Sell	21,964 -8,602	-28%	-$1.17M	0.14%	134
2023 Q4	$4.15M	Buy	30,566 +397	+1%	+$48.4K	0.21%	109
2023 Q3	$3.69M	Buy	30,169 +46	+0.2%	+$5.85K	0.21%	108
2023 Q2	$3.82M	Sell	30,123 -39	-0.1%	-$5.07K	0.2%	110
2023 Q1	$3.9M	Buy	30,162 +7	+0%	+$916	0.22%	105
2022 Q4	$3.96M	Sell	30,155 -1,930	-6%	-$249K	0.24%	103
2022 Q3	$3.75M	Sell	32,085 -30	-0.1%	-$3.73K	0.24%	105
2022 Q2	$3.78M	Buy	32,115 +223	+0.7%	+$26.5K	0.23%	110
2022 Q1	$4.16M	Buy	31,892 +1,380	+5%	+$180K	0.21%	110
2021 Q4	$4.66M	Buy	30,512 +171	+0.6%	+$26.5K	0.22%	103
2021 Q3	$4.91M	Sell	30,341 -115	-0.4%	-$19.4K	0.26%	96
2021 Q2	$4.98M	Buy	30,456 +969	+3%	+$149K	0.26%	95
2021 Q1	$4.44M	Sell	29,487 -513	-2%	-$81.5K	0.26%	98
2020 Q4	$4.54M	Sell	30,000 -607	-2%	-$86.7K	0.28%	93
2020 Q3	$4.14M	Buy	30,607 +284	+0.9%	+$38.5K	0.28%	91
2020 Q2	$4.14M	Sell	30,323 -937	-3%	-$119K	0.31%	85
2020 Q1	$3.37M	Buy	31,260 +193	+0.6%	+$22.2K	0.3%	85
2019 Q4	$3.74M	Sell	31,067 -80	-0.3%	-$8.93K	0.27%	93
2019 Q3	$3.1M	Buy	31,147 +678	+2%	+$71K	0.24%	100
2019 Q2	$3.32M	Buy	30,469 +372	+1%	+$39.6K	0.27%	96
2019 Q1	$3.36M	Sell	30,097 -922	-3%	-$101K	0.29%	91
2018 Q4	$2.99M	Sell	31,019 -750	-2%	-$79.6K	0.29%	91
2018 Q3	$3.87M	Buy	31,769 +345	+1%	+$40.6K	0.32%	84
2018 Q2	$3.45M	Buy	31,424 +3,280	+12%	+$351K	0.3%	87
2018 Q1	$3M	Buy	28,144 +1,727	+7%	+$191K	0.27%	98
2017 Q4	$2.82M	Sell	26,417 -25	-0.1%	-$2.67K	0.26%	103
2017 Q3	$2.94M	Sell	26,442 -1,095	-4%	-$117K	0.28%	97
2017 Q2	$2.85M	Buy	27,537 +2,025	+8%	+$199K	0.28%	96
2017 Q1	$2.49M	Sell	25,512 -945	-4%	-$90.5K	0.25%	108
2016 Q4	$2.34M	Sell	26,457 -210	-0.8%	-$19.1K	0.24%	106
2016 Q3	$2.57M	Buy	26,667 +570	+2%	+$54.2K	0.28%	95
2016 Q2	$2.24M	Sell	26,097 -66	-0.3%	-$5.92K	0.26%	106
2016 Q1	$2.27M	Sell	26,163 -1,020	-4%	-$91.2K	0.26%	100
2015 Q4	$3.07M	Sell	27,183 -660	-2%	-$71.6K	0.36%	77
2015 Q3	$2.82M	Buy	27,843 +276	+1%	+$33.1K	0.35%	81
2015 Q2	$3.39M	Sell	27,567 -210	-0.8%	-$25.1K	0.38%	76
2015 Q1	$3.18M	Sell	27,777 -870	-3%	-$96K	0.37%	76
2014 Q4	$2.9M	Buy	28,647 +402	+1%	+$39.1K	0.35%	85
2014 Q3	$2.58M	Sell	28,245 -15	-0.1%	-$1.32K	0.32%	90
2014 Q2	$2.42M	Buy	28,260 +9,081	+47%	+$715K	0.3%	97
2014 Q1	$1.51M	Sell	19,179 -171	-0.9%	-$14.2K	0.23%	122
2013 Q4	$1.47M	Sell	19,350 -1,875	-9%	-$133K	0.21%	124
2013 Q3	$1.48M	Hold	21,225	–	–	0.22%	123
2013 Q2	$1.23M	Buy	+21,225	New	+$1.23M	0.19%	130

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Sandy Spring Bank's IBB Position: Q1 2025 in Review

Sandy Spring Bank reduced its iShares Biotechnology ETF (IBB) stake by 0.24% in Q1 2025, selling an estimated $5.97K and leaving 17,984 shares worth $2.3M. The position accounts for 0.1% of the portfolio, ranked #163.

Sandy Spring Bank first reported a position in IBB in Q2 2013 and has held it in 48 quarters since. The position peaked at $4.98M in Q2 2021. 832 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

Sandy Spring Bank held 17,984 shares of iShares Biotechnology ETF worth $2.3M as of Q1 2025.
Sandy Spring Bank sold 44 iShares Biotechnology ETF shares in Q1 2025, an estimated $5.97K.
iShares Biotechnology ETF made up 0.1% of Sandy Spring Bank's portfolio in Q1 2025, its #163 holding.
Sandy Spring Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 48 quarters since.
Sandy Spring Bank's iShares Biotechnology ETF position peaked at $4.98M in Q2 2021.
832 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on Sandy Spring Bank's 13F filing for Q1 2025, filed 12 May 2025.